Evidence map›Paper›PMID 33872001›Full record

ArticleBioconjugate chemistry2021

Optimizing an Antioxidant TEMPO Copolymer for Reactive Oxygen Species Scavenging and Anti-Inflammatory Effects

Carlisle R DeJulius, Bryan R Dollinger, Taylor E Kavanaugh, Eric Dailing, Fang Yu, Shubham Gulati, Angelo Miskalis, Caiyun Zhang, Jashim Uddin, Sergey Dikalov and 1 more

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Transformation of a PdChemical science · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Anti-Oxidative and Anti-Inflammatory Micelles: Break the Dry Eye Vicious Cycle.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Carlisle R DeJuliusDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Bryan R DollingerDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Taylor E KavanaughDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Eric DailingDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0002-2299-7783
Fang YuDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Shubham GulatiDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Angelo MiskalisDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Caiyun ZhangDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.
Jashim UddinDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Sergey DikalovVanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Craig L DuvallDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37232, United States.ORCID 0000-0003-3979-0620
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

The Role of Inflammation in Cardiovascular DiseaseP01HL129941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2016 to 2020
$12.4M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Sirtuin 3 Inactivation and SOD2 Acetylation in Vascular Dysfunction and HypertensionR01HL157583 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DIKALOV, SERGEY · 2021 to 2024
$2.4M
Training Program for Innovative Engineering Research in Surgery and InterventionT32EB021937 · NIBIB · VANDERBILT UNIVERSITY · PI Dario J Englot, Michael Ian Miga · 2016 to 2026
$2.3M
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound HealingR01EB028690 · NIBIB · VANDERBILT UNIVERSITY · PI DUVALL, CRAIG LEWIS, GUPTA, MUKESH KUMAR · 2019 to 2023
$2.0M
Targeting Mitochondrial Cyclophilin D in Vascular Oxidative Stress and HypertensionR01HL144943 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DIKALOV, SERGEY · 2019 to 2022
$1.7M
NHLBI NIH HHS P01 HL129941NHLBI NIH HHS R01 HL144943NHLBI NIH HHS R01 HL157583NIBIB NIH HHS R01 EB028690NIBIB NIH HHS T32 EB021937NIDDK NIH HHS T32 DK101003
6 · The paper itself

Abstract

Oxidative stress is broadly implicated in chronic, inflammatory diseases because it causes protein and lipid damage, cell death, and stimulation of inflammatory signaling. Supplementation of innate antioxidant mechanisms with drugs such as the superoxide dismutase (SOD) mimetic compound 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) is a promising strategy for reducing oxidative stress-driven pathologies. TEMPO is inexpensive to produce and has strong antioxidant activity, but it is limited as a drug due to rapid clearance from the body. It is also challenging to encapsulate into micellar nanoparticles or polymer microparticles, because it is a small, water soluble molecule that does not efficiently load into hydrophobic carrier systems. In this work, we pursued a polymeric form of TEMPO [poly(TEMPO)] to increase its molecular weight with the goal of improving

Indexed as

Anti-Inflammatory AgentsAntioxidantsCyclic N-OxidesPolymersReactive Oxygen SpeciesAnimalsFree Radical ScavengersInflammationMiceOxidative StressAnti-Inflammatory AgentsAntioxidantsCyclic N-OxidesFree Radical ScavengersPolymersReactive Oxygen SpeciesTEMPO

Identifiers

PMID33872001
PMCPMC8188607
OpenAlexW3156745432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.